Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-23-018505

Options or other derivatives

  • EVP, Strategy & Innovation acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
ROBIN SHERRINGTON EVP, Strategy & Innovation 2023-03-10 Grant or award · Stock Option (Right to Buy) +75,000 75,000 D
Loading xslF345X03/doc4.xml…